Literature DB >> 2199676

'Two minutes with venus, two years with mercury'--mercury as an antisyphilitic chemotherapeutic agent.

J G O'Shea1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2199676      PMCID： PMC1292694          DOI： 10.1177/014107689008300619

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  2 in total

1.  Treatment of late benign syphilis: review of the literature.

Authors:  R K St John
Journal:  J Am Vener Dis Assoc       Date:  1976-12

2.  Serological response to syphilis treatment. A new analysis of old data.

Authors:  S T Brown; A Zaidi; S A Larsen; G H Reynolds
Journal:  JAMA       Date:  1985-03-01       Impact factor: 56.272
  2 in total
  6 in total

1.  [Giacomo Casanova (1725-1798) : a life with aphrodisiacs].

Authors:  M Hatzinger; J Hatzinger
Journal:  Urologe A       Date:  2009-04       Impact factor: 0.639

2.  After Venus, mercury: syphilis treatment in the UK before Salvarsan.

Authors:  Adriane Gelpi; Joseph D Tucker
Journal:  Sex Transm Infect       Date:  2015-02       Impact factor: 3.519

Review 3.  Brief history of syphilis.

Authors:  M Tampa; I Sarbu; C Matei; V Benea; S R Georgescu
Journal:  J Med Life       Date:  2014-03-25

4.  Quarantine as a public health measure against an emerging infectious disease: syphilis in Zurich at the dawn of the modern era (1496-1585).

Authors:  Gabriella Eva Cristina Gall; Stephan Lautenschlager; Homayoun C Bagheri
Journal:  GMS Hyg Infect Control       Date:  2016-06-06

Review 5.  [Evolution of treatment of syphilis through history].

Authors:  C Ros-Vivancos; M González-Hernández; J F Navarro-Gracia; J Sánchez-Payá; A González-Torga; J Portilla-Sogorb
Journal:  Rev Esp Quimioter       Date:  2018-11-14       Impact factor: 1.553

6.  Counting highly cited papers for university research assessment: conceptual and technical issues.

Authors:  Alonso Rodríguez-Navarro
Journal:  PLoS One       Date:  2012-10-12       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.